Frailty, which is a geriatric syndrome characterized by weakness, impaired mobility, balance, and minimal reserve, is highly prevalent in the renal population. While distinct from disability and comorbidity, some of the simplest and most clinically useful scales incorporate both the burden of medical symptoms and the effect on functional independence into the evaluation of frailty. In the renal population, the frailty phenotype has been shown to correlate with important outcomes such as hospitalization and survival. Further work is required to establish if the presence of, and the treatments used for renal disease, promote the sick role and decreased participation in exercise with overestimation of frailty or if the frailty phenotype identifies people who may benefit from rehabilitation and other interventions.

Keywords:
Frailty, Geriatric, Chronic kidney disease (CKD), End-stage renal disease (ESRD), Resilience, Dialysis initiation
1.
Hubbard RE, O'Mahony MS, Cross E, Morgan A, Hortop H, Morse RE, et al: The ageing of the population: implications for multidisciplinary care in hospital. Age Ageing 2004;33:479-482.
2.
Buchner DM, Wagner EH: Preventing frail health. Clin Geriatr Med 1992;8:1-17.
3.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146-M156.
4.
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K: Frailty in elderly people. Lancet 2013;381:752-762.
5.
Jarrett PG, Rockwood K, Carver D, Stolee P, Cosway S: Illness presentation in elderly patients. Arch Intern Med 1995;155:1060-1064.
6.
Arnold RM, Zeidel ML: Dialysis in frail elders - a role for palliative care. N Engl J Med 2009;361:1597-1598.
7.
Johansen KL, Delgado C, Bao Y, Kurella Tamura M: Frailty and dialysis initiation. Semin Dial 2013;26:690-696.
8.
Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE: Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 2009;361:1539-1547.
9.
Jassal SV, Chiu E, Hladunewich M: Loss of independence in patients starting dialysis at 80 years of age or older. N Engl J Med 2009;361:1612-1613.
10.
Shlipak MG, Stehman-Breen C, Fried LF, Song X, Siscovick D, Fried LP, et al: The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis 2004;43:861-867.
11.
Johansen KL, Chertow GM, Jin C, Kutner NG: Significance of frailty among dialysis patients. J Am Soc Nephrol 2007;18:2960-2967.
12.
Hamerman D: Toward an understanding of frailty. Ann Intern Med 1999;130:945-950.
13.
Rockwood K, Song X, Mitnitski A: Changes in relative fitness and frailty across the adult lifespan: evidence from the Canadian National Population Health Survey. CMAJ 2011;183:E487-E494.
14.
McMillan GJ, Hubbard RE: Frailty in older inpatients: what physicians need to know. QJM 2012;105:1059-1065.
15.
Rothman MD, Leo-Summers L, Gill TM: Prognostic significance of potential frailty criteria. J Am Geriatr Soc 2008;56:2211-2216.
16.
Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al: A global clinical measure of fitness and frailty in elderly people. CMAJ 2005;173:489-495.
17.
Kirkwood TBL: Understanding the odd science of aging. Cell 2005;120:437-447.
18.
Gavrilov LA, Gavrilova NS: Reliability Theory of Aging and Longevity; in Handbook of the Biology of Aging, ed 6. San Diego, CA, Academic Press, 2006.
19.
Hubbard RE, Sinead O'Mahony M, Woodhouse KW: Erythropoietin and anemia in aging and frailty. J Am Geriatr Soc 2008;56:2164-2165.
20.
Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, et al: Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002;162:2333-2341.
21.
Hubbard RE, Woodhouse KW: Frailty, inflammation and the elderly. Biogerontology 2010;11:635-641.
22.
Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, et al: Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 1998;279:585-592.
23.
Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, et al: Frailty: an emerging research and clinical paradigm - issues and controversies. J Gerontol A Biol Sci Med Sci 2007;62:731-737.
24.
Roshanravan B, Khatri M, Robinson-Cohen C, Levin G, Patel KV, de Boer IH, et al: A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis 2012;60:912-921.
25.
Kim JC, Kalantar-Zadeh K, Kopple JD: Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol 2013;24:337-351.
26.
Landau M, Kurella-Tamura M, Shlipak MG, Kanaya A, Strotmeyer E, Koster A, et al: Correlates of insulin resistance in older individuals with and without kidney disease. Nephrol Dial Transplant 2011;26:2814-2819.
27.
El-Abbadi M, Giachelli CM: Mechanisms of vascular calcification. Adv Chronic Kidney Dis 2007;14:54-66.
28.
Linden E, Cai W, He JC, Xue C, Li Z, Winston J, et al: Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol 2008;3:691-698.
29.
Painter P, Kuskowski M: A closer look at frailty in ESRD: getting the measure right. Hemodial Int 2013;17:41-49.
30.
Gill TM, Allore HG, Holford TR, Guo Z: Hospitalization, restricted activity, and the development of disability among older persons. JAMA 2004;292:2115-2124.
31.
Muller M, Smulders YM, de Leeuw PW, Stehouwer CD: Treatment of hypertension in the oldest old: a critical role for frailty? Hypertension 2014;63:433-441.
32.
Odden MC, Peralta CA, Haan MN, Covinsky KE: Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med 2012;172:1162-1168.
33.
Churchill DN, Jassal SV: Dialysis: destination or journey. J Am Soc Nephrol 2014;25:1609-1611.
34.
Vandecasteele SJ, Kurella Tamura M: A patient-centered vision of care for ESRD: dialysis as a bridging treatment or as a final destination? J Am Soc Nephrol 2014;25:1647-1651.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.